KUALA LUMPUR: The Ministry of Health (MOH) will start administering treatment with the monoclonal antibody drugs Tixagevimab and Cilgavimab (EVUSHELD) in the near future to ensure that high-risk groups continue to be protected from COVID-19 infection.
Health Minister Khairy Jamaluddin said that currently the EVUSHELD antibody drugs would only be administered in government hospitals, and they could be used as pre-exposure prophylaxis (PrEP) for those who were not yet infected with COVID19 but were at high risk of becoming infected.
"Studies show that the EVUSHELD antibody drugs can protect recipients against COVID-19 infection for a period of six months after injection," he said in a statement, today.
Khairy explained that the method of administering the antibody drugs was through two consecutive intramuscular injections of Tixagevimab and Cilgavimab.
He said for immunocompromised patients who had received the COVID-19 vaccine, EVUSHELD should be given at least two weeks after vaccination.
Commenting further, Khairy said the assessment of the patient's eligibility to receive the antibody medication would be done by the treating physician.
Among the selection criteria were those aged 12 and above; weighing more than 40kg and are among the moderate to severe Immunocompromised group (taking into account the immune response of this group to COVID-19 vaccination which is unlikely to reach a satisfactory level of immunity).
In addition, another criterion was individuals who were unable to take the vaccine completely due to medical reasons or had a history of severe reactions to the COVID-19 vaccine.
Meanwhile, Khairy said that treatment using the antiviral drug Paxlovid to treat COVID-19 patients would be extended to selected private health facilities in the near future, to ensure better access to patients.
He added that the distribution of Paxlovid medicine to patients in private health facilities is free of charge, but patients are still subject to consultation service charges and other related charges determined by the private health facility.
The use of antiviral drug Paxlovid, which has been implemented at MOH health facilities since April 15, is the first oral antiviral drug in Malaysia to treat COVID-19 patients with mild to moderate symptoms (categories two and three).
In the meantime, he said the priority of Paxlovid treatment was to the high-risk group of COVID-19 patients.
"As of June 5, 2022, a total of 1,364 patients were given Paxlovid treatment and have fully recovered, and no serious side effects have been reported. This treatment has proven to be safe and effective, and can reduce the severe effects of infection and mortality of COVID-19 patients," he said.
Khairy said that the MOH believed and was confident that Malaysia was now on the best track to go through the transition to endemic phase effectively and safely, due to the ever-improving medications and treatment methods.
-- BERNAMA
Bernama
Wed Jun 08 2022
Khairy said the MOH will start administering treatment with EVUSHELD in the near future to ensure that high-risk groups continue to be protected from COVID-19 infection. - BERNAMA
COP29 climate summit draft proposes rich countries pay $250 billion per year
The draft finance deal criticised by both developed and developing nations.
Bomb squad sent to London's Gatwick Airport after terminal evacuation
This was following the discovery of a suspected prohibited item in luggage.
Kelantan urges caution amidst northeast monsoon rains
Kelantan has reminded the public in the state to refrain from outdoor activities with the arrival of the Northeast Monsoon season.
Former New Zealand PM Jacinda Ardern receives UN leadership award
Former New Zealand prime minister Jacinda Ardern was given a global leadership award by the United Nations Foundation.
ICC'S arrest warrants for Netanyahu, Gallant an apt decision - PM
The decision of the ICC to issue arrest warrants against Benjamin Netanyahu and Yoav Gallant is apt, said Datuk Seri Anwar Ibrahim.
KTMB provides two additional ETS trains for Christmas, school holidays
KTMB will provide two additional ETS trains for the KL Sentral-Padang Besar route and return trips in conjunction with the holidays.
BNM'S international reserves rise to USD118 bil as at Nov 15, 2024
Malaysia's international reserves rose to US$118.0 billion as at Nov 15, 2024, up from US$117.6 billion on Oct 30, 2024.
Findings by dark energy researchers back Einstein's conception of gravity
The findings announced are part of a years-long study of the history of the cosmos focusing upon dark energy.
NRES responds to Rimbawatch press release on COP29
The Ministry of Natural Resources and Environmental Sustainability (NRES) wishes to offer the following clarifications to the issues raised.
Online Safety Bill and Anti-Cyberbullying Laws must carefully balance rights and protections
The Online Safety Advocacy Group (OSAG) stands united with people in Malaysia in the fight against serious online harms.
Malaysia's inflation at 1.9 pct in Oct 2024 - DOSM
Malaysia's inflation rate for October 2024 has increased to 1.9 per cent, up from 1.8 per cent in September this year.
Saudi Arabia showcases Vision 2030 goals at Airshow China 2024
For the first time, Saudi Arabia is participating in the China International Aviation & Aerospace Exhibition held recently in Zhuhai.
King Charles' coronation cost GBP 71mil, govt accounts show
The coronation of Britain's King Charles cost taxpayers GBP72 million (US$90 million), official accounts have revealed.
Couple and associate charged with trafficking 51.9 kg of meth
A married couple and a man were charged in the Magistrate's Court here today with trafficking 51.974 kilogrammes of Methamphetamine.
PDRM to consult AGC in completing Teoh Beng Hock investigation
The police may seek new testimony from existing witnesses for additional insights into the investigation of Teoh Beng Hock's death.
Thai court rejects petition over ex-PM Thaksin's political influence
Thailand's Constitutional Court rejects a petition seeking to stop Thaksin Shinawatra from interfering in the running the Pheu Thai party.
Abidin takes oath of office as Sungai Bakap assemblyman
The State Assemblyman for Sungai Bakap, Abidin Ismail, was sworn in today at the State Assembly building, Lebuh Light.
UPNM cadet officer charged with injuring junior, stomping on him with spike boots
A cadet officer at UPNM pleaded not guilty to a charge of injuring his junior by stomping on the victim's stomach with spike boots.
How Indian billionaire Gautam Adani's alleged bribery scheme took off and unraveled
The indictment was unsealed on Nov. 20, prompting a $27 billion plunge in Adani Group companies' market value.
Elon Musk blasts Australia's planned ban on social media for children
Several countries have already vowed to curb social media use by children through legislation, but Australia's policy could become one of the most stringent.